| Not Yet Recruiting | A Study to Understand How a New, Unlicensed Drug Works, Compared With a Placebo, Against BK Virus in Patients NCT07503561 | AiCuris Anti-infective Cures AG | Phase 2 |
| Not Yet Recruiting | ID-ENTITY Trial- Evaluating Serial T-ID Monitoring NCT07393594 | Transplant Genomics, Inc. | — |
| Not Yet Recruiting | Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify In NCT07347769 | University Hospital, Grenoble | — |
| Recruiting | R-MVST Cells for Treatment of Viral Infections in Children and Young Adults NCT06926894 | Columbia University | Phase 1 |
| Recruiting | Immune Registry for BK in Kidney Transplant Recipients NCT06538961 | Virginia Commonwealth University | — |
| Completed | Prediction of BK Virus Reactivation in Kidney Transplant Recipient NCT06219616 | King Chulalongkorn Memorial Hospital | N/A |
| Recruiting | Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock O NCT05101213 | M.D. Anderson Cancer Center | Phase 1 |
| Terminated | Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) NCT05511779 | SymBio Pharmaceuticals | Phase 2 |
| Recruiting | New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies NCT05264259 | University Hospital, Strasbourg, France | — |
| Recruiting | R-MVST Cells for Treatment of Viral Infections NCT05183490 | Columbia University | Phase 1 |
| Terminated | Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic C NCT05305040 | AlloVir | Phase 2 / Phase 3 |
| Completed | BK With VST for Kidney Transplant Patients NCT05042076 | University of Wisconsin, Madison | Phase 1 |
| Unknown | Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Vire NCT05026021 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia NCT04605484 | AlloVir | Phase 2 |
| Terminated | Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) NCT04390113 | AlloVir | Phase 3 |
| Recruiting | The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Trea NCT04542733 | King Chulalongkorn Memorial Hospital | N/A |
| Completed | Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic NCT04693637 | AlloVir | Phase 2 / Phase 3 |
| Completed | A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant R NCT04294472 | Vera Therapeutics, Inc. | Phase 2 |
| Unknown | Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Ce NCT05618275 | University Hospital, Strasbourg, France | — |
| Completed | Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease NCT03532971 | Dana-Farber Cancer Institute | — |
| Unknown | Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recip NCT03576014 | SL VAXiGEN | Phase 1 |
| Withdrawn | Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B) NCT02313844 | AlloVir | Phase 1 |
| Withdrawn | BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach NCT02758288 | Loma Linda University | — |
| Recruiting | Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus NCT02479698 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Ciprofloxacin for Prevention of BK Infection NCT01789203 | The Methodist Hospital Research Institute | Phase 4 |
| Completed | Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients NCT01624948 | University of California, San Francisco | Phase 4 |
| Unknown | BK Viremia After Renal Transplantation NCT00684372 | Karolinska University Hospital | N/A |
| Available | TETRAVI Expanded Access Program NCT07104591 | Baylor College of Medicine | — |